Feature Channels: Pharmaceuticals

Filters close

Not for public release

This news release is embargoed until 4-Sep-2023 5:00 PM EDT Released to reporters: 29-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Sep-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 4-Sep-2023 5:00 PM EDT Released to reporters: 29-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Sep-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Machine learning tool simplifies one of the most widely used reactions in the pharmaceutical industry
Released: 1-Sep-2023 4:25 PM EDT
Machine learning tool simplifies one of the most widely used reactions in the pharmaceutical industry
College of Liberal Arts and Sciences, University of Illinois Urbana-Champaign

University of Illinois researchers and a Swiss pharmaceutical company have developed a machine learning model that eliminates the need for extensive experimentation to determine the best conditions for an important carbon-nitrogen bond forming reaction known as the Buchwald-Hartwig reaction.

Newswise: Mapping the coronavirus spike protein could provide insight into vaccine development
Released: 1-Sep-2023 2:55 PM EDT
Mapping the coronavirus spike protein could provide insight into vaccine development
University of Missouri, Columbia

Although the COVID-19 pandemic was the first time most of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s.

Released: 31-Aug-2023 3:45 PM EDT
People who are in good shape take fewer mental-health related medication
Norwegian University of Science and Technology (NTNU)

“We find that people who are in better shape fill fewer prescriptions for anxiety and depression medications,” says Linda Ernstsen, the senior author of the article and an associate professor from the Department of Public Health and Nursing at the Norwegian University of Science and Technology (NTNU).

24-Aug-2023 5:00 PM EDT
Can Taking Statins After a Bleeding Stroke Lower Risk of Another Stroke?
American Academy of Neurology (AAN)

People who have had a stroke called an intracerebral hemorrhage who take cholesterol-lowering drugs called statins may have a lower risk of having another stroke, especially ischemic stroke, compared to people who also had an intracerebral hemorrhage but were not taking statins, according to a new study published in the August 30, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: Novel chemosensor-based method for rapid detection of bacterial toxin
Released: 30-Aug-2023 12:55 PM EDT
Novel chemosensor-based method for rapid detection of bacterial toxin
Sophia University

The COVID-19 pandemic made it very clear that we need better methods to quickly screen for dangerous pathogens and substances.

Newswise: Obesity experts spotlight safety gap in clinical trials and drug labeling for people with obesity
Released: 30-Aug-2023 10:05 AM EDT
Obesity experts spotlight safety gap in clinical trials and drug labeling for people with obesity
George Washington University

A new opinion piece published in Health Affairs Forefront raises questions around current approaches to assess drug safety and effectiveness in people with obesity.

Newswise: Researchers at UC Irvine issue a warning that GLP-1RA’s may be dangerous for children
Released: 28-Aug-2023 3:05 PM EDT
Researchers at UC Irvine issue a warning that GLP-1RA’s may be dangerous for children
University of California, Irvine

A team of clinicians, exercise scientists, pharmaceutical scholars, ethicists, and behavioral experts at the University of California, Irvine, outlined their concerns that the use of glucagon-like peptide-1 receptor agonists (GLP-1RA’s) to treat childhood obesity and type 2 diabetes may have unintended and adverse consequences for children’s health.

Released: 28-Aug-2023 11:35 AM EDT
World first drug to target form of previously untreatable life-threatening ‘bad cholesterol’
Monash University

A new drug offers a breakthrough world first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke, announced today by study lead Professor Stephen Nicholls, Director of the Monash University’s Victorian Heart Institute and Victorian Heart Hospital.

Released: 25-Aug-2023 8:05 PM EDT
SLU Study: Head and Neck Cancer Diagnostic Delays Linked to Antibiotics Despite Clinical Practice Guidelines
Saint Louis University

Researchers at Saint Louis University School of Medicine say diagnostic delays frequently occur in patients with undiagnosed head and neck cancer (HNC) and are calling for improved dissemination of current clinical practice guidelines in a new paper published Aug. 24 in JAMA Otolaryngology – Head & Neck Surgery.

Released: 25-Aug-2023 4:05 PM EDT
Weight loss medication benefits patients with heart failure and obesity
European Society of Cardiology

Semaglutide improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with heart failure with preserved ejection fraction (HFpEF) and obesity, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

Released: 25-Aug-2023 2:20 PM EDT
New Guideline Details Dental Pain Management Strategies for Pediatric Patients
American Dental Association (ADA)

Acetaminophen or non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen are recommended as first-line treatments for managing short-term dental pain in children under age 12, according to a new clinical practice guideline.

Released: 25-Aug-2023 1:45 PM EDT
New ‘promising medicines’ fund may incentivise commercialisation of high price drugs with weak evidence on clinical benefits
SAGE Publications UK

A new fund to fast-track patient access to potentially valuable new medicines may incentivise the pharmaceutical industry to develop high priced drugs for rare diseases with weak evidence on clinical benefits.

Newswise: Adrenocortical carcinoma: No mitotane for low risk of recurrence
Released: 25-Aug-2023 12:50 PM EDT
Adrenocortical carcinoma: No mitotane for low risk of recurrence
University of Würzburg

In 2017, the teams of Massimo Terzolo and Martin Fassnacht published a study in the New England Journal of Medicine that provided evidence for the efficacy of Mitotane in the prevention of recurrence in adrenocortical carcinoma.

Released: 24-Aug-2023 3:15 PM EDT
FDA approving drugs after fewer trials, providing less information to public, OSU studies find
Oregon State University

The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just a few years ago, a pair of recent studies from Oregon State University found.

Released: 24-Aug-2023 11:30 AM EDT
Altis Biosystems Launches RepliGut® Planar InflammaScreen Services to Accelerate Drug Discovery for Inflammatory Bowel Diseases
Altis Biosystems

Altis Biosystems, a leader in developing innovative, in vitro cell-based model systems for drug discovery, announces the launch of RepliGut® Planar InflammaScreen™ Services.

Released: 23-Aug-2023 2:05 PM EDT
UC Irvine-led research team leverages power of ribosomes to develop chemical libraries
University of California, Irvine

A research team led by University of California, Irvine scientists has developed an innovative method for quickly and efficiently creating vast collections of chemical compounds used in drug discovery by harnessing the power of ribosomes, the molecules found in all cells that synthesize proteins and peptides.

Newswise:Video Embedded puede-un-an-lisis-de-sangre-detectar-la-enfermedad-de-alzheimer
VIDEO
Released: 23-Aug-2023 10:05 AM EDT
¿Puede un Análisis de Sangre Detectar la Enfermedad de Alzheimer?
Cedars-Sinai

En julio, salió al mercado el primer análisis de sangre directo al consumidor diseñado para evaluar el riesgo de un usuario de desarrollar la enfermedad de Alzheimer.

Newswise: MEDIA ADVISORY: Cedars-Sinai Experts Available to Discuss Safety, Benefits of Using Medications to Lose Weight
Released: 22-Aug-2023 2:35 PM EDT
MEDIA ADVISORY: Cedars-Sinai Experts Available to Discuss Safety, Benefits of Using Medications to Lose Weight
Cedars-Sinai

The science is unclear on exactly why an increasingly popular new class of federally approved diabetes and obesity medications work, but they do know that they are effective at helping people lose weight.

Newswise:Video Embedded can-a-blood-test-detect-alzheimer-s-disease
VIDEO
Released: 22-Aug-2023 12:55 PM EDT
Can a Blood Test Detect Alzheimer’s Disease?
Cedars-Sinai

In July, the first direct-to-consumer blood test designed to assess a user’s risk for developing Alzheimer’s disease hit the market.

Not for public release

This news release is embargoed until 21-Aug-2023 5:00 PM EDT Released to reporters: 15-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 21-Aug-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Estrogen Receptor Mutation Study Suggests Potential Treatments for Endometrial Cancers
Released: 21-Aug-2023 4:55 PM EDT
Estrogen Receptor Mutation Study Suggests Potential Treatments for Endometrial Cancers
University of Utah Health

Huntsman Cancer Institute researchers studied estrogen receptor mutations and its connections to endometrial cancer. The findings led to the identification of potential personalized treatments for a cancer with limited options.

Released: 21-Aug-2023 3:20 PM EDT
New approach shows hydrogen can be combined with electricity to make pharmaceutical drugs
University of Wisconsin–Madison

The world needs greener ways to make chemicals. In a new study, University of Wisconsin–Madison researchers demonstrate one potential path toward this goal by adapting hydrogen fuel cell technologies.

Released: 21-Aug-2023 2:25 PM EDT
Genetic study shows that common medication used to prevent heart attacks may be ineffective for majority of British South Asians
Queen Mary University of London

Clopidogrel is a commonly prescribed medication used to prevent further heart attacks after an initial event. It needs to be activated in the body to be effective.

Newswise: St. Jude shows cancer resistance protein can have its cake and eat it too
Released: 21-Aug-2023 11:05 AM EDT
St. Jude shows cancer resistance protein can have its cake and eat it too
St. Jude Children's Research Hospital

Scientists at St. Jude Research Hospital unravel the mechanisms behind a key culprit in chemotherapy resistance.

Newswise: Artificial Intelligence Beyond the Clinic
Released: 21-Aug-2023 8:00 AM EDT
Artificial Intelligence Beyond the Clinic
Harvard Medical School

Artificial intelligence's impact goes beyond clinical medicine. It is reshaping science in more profound ways.

   
Newswise: Scientists Develop Efficient Spray Technique for Bioactive Materials
Released: 18-Aug-2023 1:05 PM EDT
Scientists Develop Efficient Spray Technique for Bioactive Materials
Rutgers University-New Brunswick

Rutgers scientists have devised a highly accurate method for creating coatings of biologically active materials for a variety of medical products. Such a technique could pave the way for a new era of transdermal medication, including shot-free vaccinations, the researchers said.

   
Released: 18-Aug-2023 11:45 AM EDT
Alarm as FDA fast-tracks first antipsychotic drug for agitation in dementia
BMJ

In trials, the antipsychotic drug brexpiprazole (Rexulti) failed to provide a clinically meaningful benefit and increased the risk of death. Yet the US Food and Drug Administration (FDA) has fast tracked its approval, making Rexulti the first antipsychotic for treating agitation in elderly patients with dementia.

Released: 15-Aug-2023 1:25 PM EDT
Images of enzyme in action reveal secrets of antibiotic-resistant bacteria
Emory University

Bacteria draw from an arsenal of weapons to combat the drugs intended to kill them. Among the most prevalent of these weapons are ribosome-modifying enzymes. These enzymes are growing increasingly common, appearing worldwide in clinical samples in a range of drug-resistant bacteria.

   
Newswise: Nobel Prize Laureate Who Studied Properties of Capsaicin Named 2023 Bonica Award Winner
Released: 15-Aug-2023 7:55 AM EDT
Nobel Prize Laureate Who Studied Properties of Capsaicin Named 2023 Bonica Award Winner
American Society of Regional Anesthesia and Pain Medicine (ASRA)

David Julius, PhD, who received the Nobel Prize in Medicine in 2021, has been selected to receive ASRA Pain Medicine’s 2023 John J. Bonica Award. He will present the annual lecture on Saturday, November 11, in conjunction with the 22nd Annual Pain Medicine Meeting in New Orleans, LA.

Newswise: Global Multistakeholder Panel Provides First-of-its-Kind Guidance on Assessing the Value of Biosimilar Drugs
Released: 15-Aug-2023 4:05 AM EDT
Global Multistakeholder Panel Provides First-of-its-Kind Guidance on Assessing the Value of Biosimilar Drugs
ISPOR—The Professional Society for Health Economics and Outcomes Research

ISPOR—The Professional Society for Health Economics and Outcomes Research published a new ISPOR Report that provides an overview of gaps and challenges in the value assessment of biosimilars and identifying potential approaches to address them. The report was published in the August 2023 issue of Value in Health.

Not for public release

This news release is embargoed until 14-Aug-2023 5:00 PM EDT Released to reporters: 8-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Aug-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 11-Aug-2023 9:55 AM EDT
UTHealth Houston joins SATURN trial, studying role of statins in recurrent intracerebral hemorrhage
University of Texas Health Science Center at Houston

A clinical trial evaluating the role of statins in the risk of recurrent intracerebral hemorrhage (ICH) in patients presenting with ICH, has opened for enrollment at UTHealth Houston.

Newswise: ASPET Launches Automated Patient-Oriented Problem-Solving Learning Tool
Released: 11-Aug-2023 9:40 AM EDT
ASPET Launches Automated Patient-Oriented Problem-Solving Learning Tool
Federation of American Societies for Experimental Biology (FASEB)

The American Society for Pharmacology and Experimental Therapeutics (ASPET) has automated its Automated Patient-Oriented Problem-Solving (A-POPS) learning tool.

Released: 11-Aug-2023 9:00 AM EDT
GI Multi-Society Statement Regarding GLP-1 Agonists and Endoscopy
American College of Gastroenterology (ACG)

AASLD, ACG, AGA, ASGE and NASPGHAN recognize that the new class of GLP-1 receptor agonist may be associated with delayed gastric emptying and encourage our anesthesiology, endocrinology, and industry partners to work collaboratively with our members to develop the necessary evidence to appropriately inform medication adjustments prior to elective endoscopy.

Released: 10-Aug-2023 4:05 PM EDT
Back to school: MSU experts on health and safety issues for students
Michigan State University

Over 50 million K-12 students across the United States will return to classrooms this month, according to the National Center for Education Statistics. Michigan State University experts provide guidance on how to ensure students are physically and mentally prepared for the new school year.

   
Newswise: A medication used for heart conditions improves the efficacy of current treatments for melanoma
9-Aug-2023 10:00 AM EDT
A medication used for heart conditions improves the efficacy of current treatments for melanoma
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

A collaborative study undertaken by the Navarrabiomed Biomedical Research Center (Pamplona, Navarre), the Institute of Neurosciences CSIC-UMH (Sant Joan d’Alacant, Valencian Community) and IRB Barcelona (Barcelona, Catalonia) shows that the administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma, in mouse models of this disease.

Newswise: Johns Hopkins Researchers Develop Gut-Restricted Drug to Treat IBD
Released: 10-Aug-2023 9:05 AM EDT
Johns Hopkins Researchers Develop Gut-Restricted Drug to Treat IBD
Johns Hopkins Medicine

A new study of mice and lab-grown human colon “organoids” indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical models.

Released: 10-Aug-2023 8:05 AM EDT
Rakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North Africa
Rakuten Medical, Inc.

Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell targeting therapies based on its proprietary Alluminox™ platform today announces an exclusive licensing and commercialization agreement with Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company for the Middle East and North Africa (MENA).

3-Aug-2023 4:00 PM EDT
Long-Term Use of Certain Acid Reflux Drugs Linked to Higher Risk of Dementia
American Academy of Neurology (AAN)

People who take acid reflux medications called proton pump inhibitors for four-and-a-half years or more may have a higher risk of dementia compared to people who do not take these medications, according to new research published in the August 9, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. This study does not prove that acid reflux drugs cause dementia; it only shows an association.

Released: 9-Aug-2023 11:35 AM EDT
Scientists study how a diabetes drug affects soils
Prairie Research Institute

In a recent study, Illinois Sustainable Technology Center environmental chemist Wei Zheng and colleagues investigated the adsorption of sitagliptin in soils treated with sewage wastewater.

Released: 8-Aug-2023 5:40 PM EDT
How psychedelic drugs affect a rat’s brain
Lund University

Researchers at Lund University have developed a technique for simultaneously measuring electrical signals from 128 areas of the brain in awake rats.

Newswise: Big Data. Bigger Opportunities.
Released: 8-Aug-2023 1:20 PM EDT
Big Data. Bigger Opportunities.
Sanford Burnham Prebys

New and rapidly developing technologies, such as cryo-electron (cryo-EM) and artificial intelligence, are providing the tools to revolutionize biomedical research, but you need scientists who know how to use them

   
Newswise: Chulalongkorn’s Faculty of Pharmaceutical Sciences Presents Plant-Based Biopharmaceutical Research to Combat Cancer Cells in Lab Animals
Released: 8-Aug-2023 8:55 AM EDT
Chulalongkorn’s Faculty of Pharmaceutical Sciences Presents Plant-Based Biopharmaceutical Research to Combat Cancer Cells in Lab Animals
Chulalongkorn University

For the first time in Thailand, lecturers at Chulalongkorn University’s Faculty of Pharmaceutical Sciences have successfully developed antibody from tobacco plants with inhibitory effects on the growth of cancer cells in laboratory animals. This signals hope for access to effective cancer medication and treatment at a lower cost.

   
Newswise: Opioids, Methadone and Babies
Released: 8-Aug-2023 6:05 AM EDT
Opioids, Methadone and Babies
Children's Hospital Los Angeles

A new study led by Lorraine Kelley-Quon, MD, MSHS, pediatric surgeons at Children’s Hospital Los Angeles shows that methadone use in babies after surgery can lead to longer hospital stays.

Released: 7-Aug-2023 5:05 PM EDT
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study
Scripps Research Institute

An antibody in single-chain fragment variable (scFv) format that binds to the powerful opioid carfentanil was shown to reverse signs of carfentanil overdose in preclinical tests conducted by scientists at Scripps Research.

Not for public release

This news release is embargoed until 7-Aug-2023 5:00 PM EDT Released to reporters: 1-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 7-Aug-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.



close
2.33819